FIVE PRIME THERAPEUTICS INC (32) | Human Resources (10)

Browse by Subcategory

Recent Contracts

Retention Letter Agreement by and between the company and Helen Collins, dated as of January 15, 2020 (Filed With SEC on February 27, 2020)
Executive Severance Benefit Plan and Summary Plan Description, effective November 20, 2019 (Filed With SEC on February 27, 2020)
Non-Employee Director Compensation Policy, effective November 21, 2019 (Filed With SEC on February 27, 2020)
Separation Agreement by and between the company and Aron M. Knickerbocker, dated as of September 19, 2019 (Filed With SEC on November 6, 2019)
Consulting Agreement by and between the company and Lewis T. Williams, effective as of April 1, 2019 (Filed With SEC on May 9, 2019)
Retention Letter Agreement by and between the company and David V. Smith, dated as of January 15, 2020 (Filed With SEC on February 27, 2020)
Retention Letter Agreement by and between the company and Francis Sarena, dated as of January 15, 2020 (Filed With SEC on February 27, 2020)
Executive Severance Benefits Agreement by and between the company and Bryan Irving, dated as of September 5, 2017 (Filed With SEC on February 26, 2019)
Executive Severance Benefits Agreement by and between the company and David V. Smith, dated as of November 26, 2018 (Filed With SEC on February 26, 2019)
Amendment No. 1 to the Confidential Consulting Agreement by and between the company and FLG Partners, LLC, dated as of October 13, 2018.v (Filed With SEC on February 26, 2019)